Blayo, Claire

Brureau, Anthony

Delair, Brice

Givalois, Laurent

Ixart, Guy

Keller, Emeline

Marchal, Stéphane

Maurice, Tangui,

Zussy, Charleine

PLoS ONE

PubMed

Charleine Zussy

Anthony Brureau

Emeline Keller

Stéphane Marchal

Claire Blayo

Brice Delair

Guy Ixart

Tangui Maurice

Laurent Givalois

Crossref

Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats

Maurice, Tangui, Tm

HAL-CIRAD

Alzheimer's disease (AD) is a neurodegenerative pathology associated with aging characterized by the presence of senile plaques and neurofibrillary tangles that finally result in synaptic and neuronal loss. The major component of senile plaques is an amyloid-β protein (Aβ). Recently, we characterized the effects of a single intracerebroventricular (icv) injection of Aβ fragment (25-35) oligomers (oAβ(25-35)) for up to 3 weeks in rats and established a clear parallel with numerous relevant signs of AD. To clarify the long-term effects of oAβ(25-35) and its potential role in the pathogenesis of AD, we determined its physiological, behavioral, biochemical and morphological impacts 6 weeks after injection in rats. oAβ(25-35) was still present in the brain after 6 weeks. oAβ(25-35) injection did not affect general activity and temperature rhythms after 6 weeks, but decreased body weight, induced short- and long-term memory impairments, increased corticosterone plasma levels, brain oxidative (lipid peroxidation), mitochondrial (caspase-9 levels) and reticulum stress (caspase-12 levels), astroglial and microglial activation. It provoked cholinergic neuron loss and decreased brain-derived neurotrophic factor levels. It induced cell loss in the hippocampic CA subdivisions and decreased hippocampic neurogenesis. Moreover, oAβ(25-35) injection resulted in increased APP expression, Aβ(1-42) generation, and increased Tau phosphorylation. In conclusion, this in vivo study evidenced that the soluble oligomeric forms of short fragments of Aβ, endogenously identified in AD patient brains, not only provoked long-lasting pathological alterations comparable to the human disease, but may also directly contribute to the progressive increase in amyloid load and Tau pathology, involved in the AD physiopathology

Directory of Open Access Journals

Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats.

Hal-Diderot

HAL Descartes

A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Ab(25–35).

A single brainderived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats.

A single social stressexperience alters glutamate receptor-binding in rat hippocampal CA3 area.

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Adrenalectomy attenuates stressinduced elevations in extracellular glutamate concentration in the hippocampus.

Alzheimer’s disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.

Alzheimer’s disease: From pathology to therapeutic approaches.

Alzheimer’s disease: Genes, proteins, and therapy.

Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Alzheimer’s disease.

Amyloid-b protein immunotherapy neutralizes Ab oligomers that disrupt synaptic plasticity in vivo.

Amyloid-b(25–35)-induced memory impairments correlate with cell loss in rat hippocampus.

An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12.

Animal models of Alzheimer’s disease and evaluation of anti-dementia drugs.

Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative Anavex1–41 against amyloid-b25–35-induced toxicity in mice.

Attenuation by a sigma1 receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats.

Attenuation of Ab-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress.

b-amyloid increases somatostatin expression in cultured cortical neurons.

b-amyloid-induced endothelial necrosis and inhibition of nitric oxide production.

b-protein/a4 deposits are not associated with hyperphosphorylated Tau in somatostatin neurons in the hypothalamus of Alzheimer’s disease patients.

Bilateral injections of amyloid-beta 25–35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects.

Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Chronic corticosterone administration dose-dependently modulates Ab(1–42)-and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis.

Commentary: Ab N-terminal isoforms: Critical contributors in the course of Alzheimer’s disease pathophysiology.

Comparison of bprotein/a4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer’s disease patients: Amorphic plaques and cytoskeletal changes occur independently.

Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease.

Cortisol and Alzheimer’s disease, I: Basal studies.

Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway.

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brainderived neurotrophic factor level and activating TrkB.

Different mechanisms of oxidative stress and neurotoxicity for Alzheimer’s Ab(1–42) and Ab(25–35).

Differential neuroimmune markers to the onset of Alzheimer’s disease neurodegeneration and dementia: Autoantibodies to Ab(25–35) oligomers, S100b and neurotransmitters.

Diffusible, nonfibrillar ligands derived from Ab(1–42) are potent central nervous system neurotoxins.

Drastic neuronal loss in vivo by bamyloid racemized at Ser(26) residue: Conversion of non-toxic [D-Ser(26)]Ab 1– 40 to toxic and proteinase-resistant fragments.

Effects of Ab(25–35) on neurogenesis in the adult mouse subventricular zone and dentate gyrus.

Effects of amyloid-b (25–35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.

Effects of neurotrophins on synaptic protein expression in the visual cortex of dark-reared rats.

Effects of Tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid b-peptide (25–35).

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid bpeptide toxicity in hippocampal neurons.

Expression of BDNF and its receptors in the median eminence cells with sensitivity to stress. Endocrinology 135: 4737–4747. Long-Term Effects of Oligomeric Amyloid-b Peptide

High plasma levels of cortisol in patients with senile dementia of the Alzheimer’s type.

Human caspases: Activation, specificity, and regulation.

Imipramine, in part through tumor necrosis factor inhibition, prevents cognitive decline and -amyloid accumulation in a mouse model of Alzheimer’s Disease.

Immunochemical and morphometric features of astrocyte reactivity vs. plaque location in Alzheimer’s disease.

In vitro aggregation facilities b-amyloid peptide-(25–35)-induced amnesia in the rat.

In vivo conversion of racemized b-amyloid ([D-Ser 26]Ab 1–40) to truncated and toxic fragments ([DSer 26] Ab 25–35/40) and fragment presence in the brains of Alzheimer’s patients.

Long-Term Effects of Oligomeric Amyloid-b Peptide

Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer’s disease.

Microglial cells around amyloid plaques in Alzheimer’s disease express leucocyte adhesion molecules of the lfa-1 family.

Molecular features of hypothalamic plaques in Alzheimer’s disease.

Natural oligomers of the amyloid-b protein specifically disrupt cognitive function.

Neurodegeneration induced by b-amyloid peptides in vitro: The role of peptide assembly state.

Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer’s disease.

Neuropathological stageing of Alzheimer-related changes.

Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways.

Neurotrophic and neurotoxic effects of amyloid-b protein: Reversal by tachykinin neuropeptides.

Pathways towards and away from Alzheimer’s disease.

Phases of Ab-deposition in the human brain and its relevance for the development of Alzheimer’s disease.

Physicochemical characteristics of soluble oligomeric Ab and their pathologic role in Alzheimer’s disease.

Privat A

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

Protective effect of Puerarin on b-amyloidinduced neurotoxicity in rat hippocampal neurons.

Proteomic analysis of glial fibrillary acidic protein in Alzheimer’s disease and aging brain.

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

Quantification of lipid peroxidation in tissue extracts based on fe(iii)xylenol orange complex formation.

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

Regulation of apoptosis by endoplasmic reticulum pathways.

Role of brain-derived neurotrophic factor in the protective action of N-methyl-D-aspartate in the apoptotic death of cerebellar granule neurons induced by low potassium.

Santucci A

Selkoe DJ (2007) Ab oligomers - A decade of discovery.

Single intracerebroventricular administration of amyloid-b(25–35) peptide induces impairment in short-term rather than long-term memory in rats.

Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases.

Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid b-peptide.

Structure-activity analyses of b-amyloid peptides: Contributions of the b 25–35 region to aggregation and neurotoxicity.

Studies of the effects of central administration of b-amyloid peptide (25– 35): pathomorphological changes in the Hippocampus and impairment of spatial memory.

The amyloidogenic potential and behavioral correlates of stress.

The anti-amnesic and neuroprotective effects of donepezil against amyloid-b (25–35) peptide-induced toxicity in mice involve an interaction with the sigma(1) receptor.

The extensive nitration of neurofilament light chain in the hippocampus is associated with the cognitive impairment induced by amyloid-b in mice.

The inflammatory response in Alzheimer’s disease.

The pattern of human Tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.

The rat brain in stereotaxic coordinates.

The role of cell-derived oligomers of Ab in Alzheimer’s disease and avenues for therapeutic intervention.

The significance of neuroinflammation in understanding Alzheimer’s disease.

Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid-b fragment in rats.

Und Halbach O

Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats

Abstract

Similar works

Full text

Available Versions

Crossref

HAL-CIRAD

Directory of Open Access Journals

Hal-Diderot

HAL Descartes